Stockscreener 앱 받기
13.99
3.58%
-0.52
전일 마감가:
$14.51
열려 있는:
$14.44
하루 거래량:
236.60K
Relative Volume:
0.64
시가총액:
$704.55M
수익:
$62.02M
순이익/손실:
$-45.65M
주가수익비율:
-15.21
EPS:
-0.92
순현금흐름:
$-9.60M
1주 성능:
-2.91%
1개월 성능:
+2.57%
6개월 성능:
+66.75%
1년 성능:
+73.57%
1일 변동 폭
$13.85
$14.44
1주일 범위
$13.85
$15.15
52주 변동 폭
$7.90
$15.15
Theravance Biopharma Inc Stock (TBPH) Company Profile
명칭
Theravance Biopharma Inc
전화
650-808-6000
주소
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
TBPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
13.99 | 730.74M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-12 | 개시 | B. Riley Securities | Buy |
| 2024-08-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | 개시 | BTIG Research | Buy |
| 2024-01-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-11-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2021-08-25 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | 개시 | JP Morgan | Overweight |
| 2020-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-05-13 | 개시 | Cowen | Outperform |
| 2020-01-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-06 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | 개시 | H.C. Wainwright | Buy |
| 2018-03-29 | 재개 | Piper Jaffray | Overweight |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-06-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-12-21 | 개시 | Needham | Buy |
| 2016-11-03 | 개시 | Piper Jaffray | Overweight |
| 2016-10-12 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | 개시 | Guggenheim | Buy |
| 2016-06-20 | 재확인 | Leerink Partners | Outperform |
| 2016-05-12 | 개시 | Leerink Partners | Outperform |
| 2016-05-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
모두보기
Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스
Top chart patterns to watch in Theravance Biopharma Inc.Trade Volume Summary & Real-Time Buy Zone Alerts - newser.com
Will breakout in Theravance Biopharma Inc. lead to full recovery2025 Historical Comparison & Long-Term Capital Growth Strategies - newser.com
Theravance Biopharma Inc. stock volume spike explainedEarnings Growth Report & Consistent Profit Trading Strategies - newser.com
Theravance Biopharma Hits New 52-Week High of $15.15, Up 67.59% - Markets Mojo
How to integrate Theravance Biopharma Inc. into portfolio analysis tools2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com
Analysts Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $23.00 - Defense World
Relative strength of Theravance Biopharma Inc. in sector analysisEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
Is Theravance Biopharma Inc. (0TB) stock positioned for secular growthJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
What analysts say about Theravance Biopharma Inc stockInsider Trading Compliance & Build Capital Safely - earlytimes.in
Theravance Biopharma (NASDAQ:TBPH) Earns "Hold (C)" Rating from Weiss Ratings - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Earns “Hold (C)” Rating from Weiss Ratings - Defense World
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Sets New 12-Month HighTime to Buy? - MarketBeat
Identifying reversal signals in Theravance Biopharma Inc.Weekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Published on: 2025-10-06 07:12:34 - newser.com
Can swing trading help recover from Theravance Biopharma Inc. lossesWeekly Risk Summary & Weekly Watchlist for Hot Stocks - newser.com
Will Theravance Biopharma Inc. benefit from macro trendsJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com
How to manage a losing position in Theravance Biopharma Inc.Watch List & Verified Short-Term Plans - newser.com
Can Theravance Biopharma Inc. (0TB) stock hit consensus price targetsJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - newser.com
Can Theravance Biopharma Inc. (0TB) stock double in coming years2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
What insider purchases suggest about Theravance Biopharma Inc. (0TB) stockProduct Launch & Weekly High Conviction Ideas - newser.com
Published on: 2025-10-03 07:08:04 - newser.com
Leading vs lagging indicators on Theravance Biopharma Inc. performanceJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
What RSI levels show for Theravance Biopharma Inc. (0TB) stock2025 Top Decliners & Risk Controlled Daily Plans - newser.com
Theravance Biopharma Inc. stock momentum explainedWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Voya Investment Management LLC Reduces Stock Holdings in Theravance Biopharma, Inc. $TBPH - Defense World
Theravance Biopharma, Inc. $TBPH Shares Bought by Ballentine Partners LLC - Defense World
Theravance Biopharma Hits New 52-Week High of $14.87, Up 67.82% - Markets Mojo
Will Theravance Biopharma Inc. outperform the market2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Theravance Biopharma Inc Stock Analysis and ForecastStock Rotation Strategies & Build Balanced Portfolio - earlytimes.in
Theravance Biopharma (NASDAQ:TBPH) Reaches New 12-Month HighHere's What Happened - MarketBeat
Theravance Biopharma Inc (TBPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):